Antimicrobial Resistance and Resistance Determinant Insights into Multi-Drug Resistant Gram-Negative Bacteria Isolates from Paediatric Patients in China

References

• Kate EJ, Nikkita GP, Marc AL, et al. Global trends in emerging infectious diseases. Nature. 2008;451:990–993. doi:10.1038/nature0653618288193
   PubMed Web of Science ®Google Scholar
• Dawood Y, Tamara J, Sajeda K, Rawan AR, Wasim K, Miral A. Community-acquired serious bacterial infections in the first 90 days of life: a revisit in the era of multi-drug-resistant organisms. World J Pediatr. 2019. doi:10.1007/s12519-019-00276-w
   Web of Science ®Google Scholar
• Spyridon K, Hamid B, George S, Michael M, Constantinos T. Intravenous colistin use for infections due to MDR GNB in critically ill paediatric patients: a systematic review and meta-analysis. J Antimicrob Chemother. 2019 print ahead. doi:doi:10.1093/jac/dkz165.
   Web of Science ®Google Scholar
• Martin E, Sanjay B, Bärbel C, et al. Antibiotic resistance: what is so special about multidrug-resistant Gram-negative bacteria? GMS Hyg Infect Control. 2017;12:1–24. doi:10.3205/dgkh000290
   Web of Science ®Google Scholar
• Baym M, Stone K, Kishony R. Multidrug evolutionary strategies to reverse antibiotic resistance. Science. 2016;351:aad3292. doi:10.1126/science.aad329226722002
   PubMed Web of Science ®Google Scholar
• Alison H, Luke P, Arnfinn S, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2015;387(100140):176–187. doi:10.1016/S01406736(15)00473-0.26603922
   PubMedGoogle Scholar
• Étienne R, Paul-Louis W, François B. Mechanisms of antimicrobial resistance in GNB. Ann Intensive Care. 2015;5:21. doi:doi:10.1186/s13613-015-0061-0
   Web of Science ®Google Scholar
• Colodner R, Rock W, Chazan B, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in non-hospitalized patients. Eur J Clin Microbiol Infect Dis. 2004;23(3):163–167. doi:10.1007/s10096-003-1084-214986159
   PubMed Web of Science ®Google Scholar
• Ayukekbong A, Ntemgwa M, Atabe N. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6(1):47. doi:10.1186/s13756-017-0208-x.28515903
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antimicrobial Resistance: Global Report on Surveillance. World Health Organization; 2014.
   Google Scholar
• Fernando M, Luke W, Miththinda J, et al. Extended spectrum beta-lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern – a hospital based cross sectional study. BMC Infect Dis. 2017;17(1):138. doi:10.1186/s12879-017-2250-y.28187754
   PubMed Web of Science ®Google Scholar
• Pitout D, Laupland B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159–166. doi:10.1016/S1473-3099(08)70041-018291338
   PubMed Web of Science ®Google Scholar
• Queenan M, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20(3):440–458. doi:doi:10.1128/CMR.00001-0717630334
   PubMed Web of Science ®Google Scholar
• Chang-Ro L, Jung L, Kwang P, Young K, Byeong J, Sang L. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol. 2016;7:895. doi:10.3389/fmicb.2016.0089527379038
   PubMed Web of Science ®Google Scholar
• Stoesser N, Sheppard E, Peirano G, et al. Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli. Sci Rep. 2017;7(1):5917. doi:10.1038/s41598-017-06256-228725045
   PubMed Web of Science ®Google Scholar
• Mao T, Zhai H, Duan G, Yang H. Patterns of drug-resistant bacteria in a General Hospital, China, 2011–2016. Pol J Microbiol. 2019;68(2):225–232. doi:doi:10.33073/pjm-2019-024.31250593
   PubMed Web of Science ®Google Scholar
• Sandip P, Xiaowen C, Ma L, Feiqiu W. Phenotypic and genotypic characterization of multi-drug-resistant Escherichia coli isolates harbouring blaCTX-M group extended-spectrum β-lactamases recovered from pediatric patients in Shenzhen, southern China. Infect and Drug Resist. 2019;12:1325–1332. doi:10.2147/IDR.S19986131190921
   PubMedGoogle Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth Informational Supplement; 2010 Available from: https://clsi.org/. Accessed 56, 2019.
   Google Scholar
• Kim Z, Angela H, Gerlinde P, Hester B, Albert N, Leo S. The Carbapenem Inactivation Method (CIM), a simple and low-cost alternative for the carba NP test to assess phenotypic carbapenemase activity in gram-negative rods. PLoS One. 2015;10(3):e0123690. doi:doi:10.1371/journal.pone.012369025798828
   PubMed Web of Science ®Google Scholar
• Yi-Yun L, Yang W, Timothy W, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168. doi:doi:10.1016/S1473-3099(15)00424-726603172
   PubMed Web of Science ®Google Scholar
• Yee-Huang K, Mei-Feng L, Yin-Ching C, Wen-Liang Y. Detection of plasmid-mediated β-Lactamase genes and emergence of a novel AmpC (CMH-1) in Enterobacter cloacae at a medical Center in Southern Taiwan. J Clin Med. 2019;8(1):8. doi:10.3390/jcm8010008
   Web of Science ®Google Scholar
• Tian B, Huang M, Fang L, Qing Y, Zhang F, Huang X. CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like beta-lactamases identified in an Escherichia coli clinical isolate. J Antimicrob Chemother. 2014;69(8):2081–2085. doi:10.1093/jac/dku12624777903
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey R, et al. Multidrug-resistant, extensively drug-resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Hye Sun H, Ji Hye K, Myung Hyun C, Eujin P. Low relapse rate of urinary tract infections from extended-spectrum beta-lactamase-producing bacteria in young children. Pedi Nephro. 2019. in press. doi:doi:10.1007/s00467-019-04298-4.
   Web of Science ®Google Scholar
• Khalili H, Afhami S, Dashti-Khavidaki S, Alijani B. Antimicrobial resistance pattern of Gram-negative bacteria of nosocomial origin at a teaching hospital in the Islamic Republic of Iran. Eastern Medi Terranean Health J. 2012;18(2):172–177. doi:10.26719/2012.18.2.172
   Google Scholar
• Woolhouse ME, Ward MJ. Sources of antimicrobial resistance. Science. 2013;341(6153):1460–1461. doi:10.1126/science.1243444.24030495
   PubMed Web of Science ®Google Scholar
• Dong L, Zhang XY, Li CC, Li Z, Xia YQ. Characteristics of epidemiology and antimicrobial resistance of gram-negative bacterial bloodstream infections in children. Chin J Paediatr. 2017;55(9):683–688. doi:10.3760/cma.j.issn.0578-1310.2017.09.012.
   Google Scholar
• Gales AC, Castanheira M, Jones RN, Sader HS. Antimicrobial resistance among GNB isolated from Latin America: results from SENTRY antimicrobial surveillance program (Latin America, 2008–2010). Diagn Microbiol Infect Dis. 2012;73(4):354–360. doi:doi:10.1016/j.diagmicrobio.2012.04.00722656912
   PubMed Web of Science ®Google Scholar
• Fei H, Wei-Yang L, Jiun-Ling W, et al. Faecal carriage of multidrug-resistant Escherichia coli by community children in southern Taiwan. BMC Gastroenterol. 2018;18(86):1–8. doi:doi:10.1186/s12876-017-0727-129301491
   PubMed Web of Science ®Google Scholar
• Parajuli NP, Acharya SP, Mishra SK, Parajuli K, Rijal BP, Pokhrel BM. High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal. Antimicrob Resist Infect Control. 2017;6(1):67. doi:10.1186/s13756-017-0222-z.28638594
   PubMed Web of Science ®Google Scholar
• Shukla I, Tiwari R, Agrawal M. Prevalence of extended spectrum-lactamase producing Klebsiella pneumoniae in a tertiary care hospital. Indian J Med Microbiol. 2004;22(2):87.17642702
   PubMedGoogle Scholar
• Wellington EM, Boxall AB, Cross P, et al. The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria. Lancet Infect Dis. 2013;13(2):155–165. doi:10.1016/S1473-3099(12)70317-123347633
   PubMed Web of Science ®Google Scholar
• Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr. 2016;4(2):1–37. doi:10.1128/microbiolspec.VMBF-0016-2015
   Web of Science ®Google Scholar
• Hughes D. Exploiting genomics, genetics and chemistry to combat antibiotic resistance. Nat Rev Genet. 2003;4(6):432–441. doi:10.1038/nrg1084(2003)12776213
   PubMed Web of Science ®Google Scholar
• Gelband H, Laxminarayan R. Tackling antimicrobial resistance at global and local scales. Trends Microbiol. 2015;23(9):524–526. doi:10.1016/j.tim.2015.06.00526338444
   PubMed Web of Science ®Google Scholar
• Sonda T, Kumburu H, Van Zwetselaar M, et al. Prevalence and risk factors for CTX-M gram-negative bacteria in hospitalized patients at a tertiary care hospital in Kilimanjaro, Tanzania. Eur J Clin Microbiol Infect Dis. 2018;37(5):897–906. doi:10.1007/s10096-018-3196-8.29464424
   PubMed Web of Science ®Google Scholar
• Shin-ichi F, Kentaro Y, Thikako O, Kouhei U, Yukiko T, Yasuko S. Rapid identification of gram-negative bacteria with and without CTX-M extended-spectrum β-Lactamase from positive blood culture bottles by PCR Followed by microchip gel electrophoresis. J Clin Microbiol. 2011;49(4):1483–1488. doi:doi:10.1128/JCM.01976-1021289149
   PubMed Web of Science ®Google Scholar
• Li S, Zhao M, Liu J, Zhou Y, Miao Z. Prevalence and antibiotic resistance profiles of extended-spectrum β-lactamase-producing isolated from healthy broilers in Shandong province, China. J Food Prot. 2016;79(7):1169–1173. doi:doi:10.4315/0362-028X.JFP-16-025.27357036
   PubMed Web of Science ®Google Scholar
• Ma J, Liu J-H, Lv L, et al. Characterization of extended-spectrum β-lactamase genes found among Escherichia coli isolates from duck and environmental samples obtained on a duck farm. Appl Environ Microbiol. 2012;78(10):3668–3673. doi:doi:10.1128/AEM.07507-11.22407683
   PubMed Web of Science ®Google Scholar
• Ruobing W, Lucy VD, Liam P, et al. The global distribution and spread of the mobilized colistin resistance gene mcr-1. Nat Commun. 2018;9:1179. doi:10.1038/s41467-018-03205-z29563494
   PubMed Web of Science ®Google Scholar